652 related articles for article (PubMed ID: 15755578)
41. An exercise on the feasibility of carrying out secondary economic analyses.
Jefferson T; Mugford M; Gray A; Demicheli V
Health Econ; 1996; 5(2):155-65. PubMed ID: 8733107
[TBL] [Abstract][Full Text] [Related]
42. Economic evaluation of drugs in peripheral vascular disease and stroke.
Drummond M; Davies L
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S4-7. PubMed ID: 7517476
[TBL] [Abstract][Full Text] [Related]
43. Emerging issues in vaccine economics: perspectives from the USA.
Lieu TA; Thompson KM; Prosser LA; O'Brien MA; Yusuf HR; Shefer AM; Weinstein MC; Rickert DL
Expert Rev Vaccines; 2002 Dec; 1(4):433-42. PubMed ID: 12901581
[TBL] [Abstract][Full Text] [Related]
44. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
45. Economic evaluation of health care technologies.
Jönsson B
Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():50-4. PubMed ID: 8342394
[TBL] [Abstract][Full Text] [Related]
46. Expensive care - a rationale for economic evaluations in intensive care.
Higgins AM; Pettila V; Bellomo R; Harris AH; Nichol AD; Morrison SS
Crit Care Resusc; 2010 Mar; 12(1):62-6. PubMed ID: 20196716
[TBL] [Abstract][Full Text] [Related]
47. Economic aspects in prolonged life sustainable treatments.
Borgonovi E
NeuroRehabilitation; 2004; 19(4):367-71. PubMed ID: 15671592
[TBL] [Abstract][Full Text] [Related]
48. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
Ijzerman MJ; Steuten LM
Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
[TBL] [Abstract][Full Text] [Related]
49. Economic issues in the development and use of practice guidelines: an application to resource allocation in dentistry.
Birch S; Leake JL; Lewis DW
Community Dent Health; 1996 Jun; 13(2):70-5. PubMed ID: 8763135
[TBL] [Abstract][Full Text] [Related]
50. Pharmacoeconomics.
Ahuja J; Gupta M; Gupta AK; Kohli K
Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
[TBL] [Abstract][Full Text] [Related]
51. Health economics--concepts and conceptual problems.
Satpathy SK; Bansal RD
Health Popul Perspect Issues; 1982; 5(1):23-33. PubMed ID: 10310083
[TBL] [Abstract][Full Text] [Related]
52. Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine.
Evans DB; Guyatt HL
Trop Med Int Health; 1997 Nov; 2(11):A47-54. PubMed ID: 9391522
[TBL] [Abstract][Full Text] [Related]
53. [Introduction to methods of economic modelling: a primer for orthopaedic surgeons and traumatologists].
Vavken P; Dorotka R
Z Orthop Unfall; 2009; 147(4):419-23. PubMed ID: 19771671
[TBL] [Abstract][Full Text] [Related]
54. Economic perspectives on pediatric obesity: impact on health care expenditures and cost-effectiveness of preventive interventions.
John J
Nestle Nutr Workshop Ser Pediatr Program; 2010; 66():111-24. PubMed ID: 20664220
[TBL] [Abstract][Full Text] [Related]
55. The use of health economic information by reimbursement authorities.
Drummond MF
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii60-3. PubMed ID: 14585919
[TBL] [Abstract][Full Text] [Related]
56. Economic evaluations of hepatitis A vaccination in middle-income countries.
Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ
Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129
[TBL] [Abstract][Full Text] [Related]
57. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
Delwel GO; Sprenger MJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
[TBL] [Abstract][Full Text] [Related]
58. Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm.
Jacobson SH; Karnani T; Sewell EC
Vaccine; 2004 Jun; 22(17-18):2307-15. PubMed ID: 15149790
[TBL] [Abstract][Full Text] [Related]
59. Criteria for inclusion of vaccinations in public programmes.
Houweling H; Verweij M; Ruitenberg EJ;
Vaccine; 2010 Apr; 28(17):2924-31. PubMed ID: 20189486
[TBL] [Abstract][Full Text] [Related]
60. [Medical economy--a new challenge for physicians].
Beeler I; Szucs TD
Praxis (Bern 1994); 2000 May; 89(20):861-7. PubMed ID: 10865509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
